Navigating the risks and rewards
Over the last few years, we have seen the transition from traditionally printed material to electronic format. Everything from books, magazines, newspapers and instructions on how to build something can be accessed in a digital manner. But the Pharma industry, specifically clinical, has typically been more risk averse and perhaps behind the times when it comes to these progressive ideas.
Recently there has been a push to shift traditionally printed drug labels into an electronic format for patients participating in clinical trials. While an easy solution at first glance, there are many things that must be considered including cost, timelines, contingency plans and patient safety.
Join us on 13th July when we will discuss eLabels and what this means for the industry, how it impacts regulatory limitations and most importantly, how it impacts the patients. During the webinar we will outline the pros and cons of an elabel solution in a clinical trial environment.
Presented by
Kevin Shea,
Senior Label Program Director
Kevin currently serves as the Senior Label Program Director - Clintrak Clinical Labeling (Bohemia) and has been with Fisher Clinical Services since May 2006. His experience in clinical labels and label translation services spans many years previously holding positions like production coding, label design and project management.
With a Bachelor’s Degree in English from Hobart College, Kevin likes to balance his work with quality family time and his relatively new pastime, golf.
